Methot Joey L, Achab Abdelghani, Christopher Matthew, Zhou Hua, McGowan Meredeth A, Trotter B Wesley, Fradera Xavier, Lesburg Charles A, Goldenblatt Peter, Hill Armetta, Chen Dapeng, Otte Karin M, Augustin Martin, Shah Sanjiv, Katz Jason D
Discovery Chemistry, Computational and Structural Chemistry, In Vitro Pharmacology, Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co., Inc., Boston, Massachusetts 02115, United States.
Proteros Biostructures, Martinsried 82152, Germany.
ACS Med Chem Lett. 2020 Nov 19;11(12):2461-2469. doi: 10.1021/acsmedchemlett.0c00441. eCollection 2020 Dec 10.
The 3,3-disubstituted oxindole moiety is a versatile and rigid three-dimensionally shaped scaffold. When engineered with a purine hinge-binding core, exceptionally selective PI3Kδ kinase inhibitors were discovered by exploiting small differences in isoform selectivity pockets. Crystal structures of early lead bound to PI3Kδ and PI3Kα helped rationalize the high selectivity observed with . By attenuating the lypophilicity and metabolic liabilities of an oxindole moiety, we improved the preclinical species PK and solubility and reduced adenosine uptake activity. The excellent potency and kinome selectivity of 7-azaoxindole and spirooxindole , together with a low plasma clearance and good half-life in rat and dog, supported a low once-daily predicted human dose.
3,3-二取代氧化吲哚部分是一种通用且刚性的三维形状支架。当与嘌呤铰链结合核心进行工程化设计时,通过利用同工型选择性口袋中的微小差异,发现了具有异常选择性的PI3Kδ激酶抑制剂。早期先导化合物与PI3Kδ和PI3Kα结合的晶体结构有助于解释所观察到的高选择性。通过减弱氧化吲哚部分的亲脂性和代谢负担,我们改善了临床前物种的药代动力学和溶解度,并降低了腺苷摄取活性。7-氮杂氧化吲哚和螺氧化吲哚的优异效力和激酶组选择性,以及在大鼠和犬中的低血浆清除率和良好半衰期,支持了每日一次的低预测人体剂量。